ADAM and ADAMTS Proteases in Hepatic Disorders
Journal of Renal and Hepatic Disorders · 2019
DOI: 10.15586/jrenhep.2019.47 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Renal and Hepatic Disorders, 2019. Verfasst von Julia Bolik und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Proteolysis is an irreversible post-translational modification that regulates protein function and signal transduction. This includes remodelling of the extracellular matrix, release of membrane-bound cytokines and receptor ectodomains, as well as the initiation of intracellular signalling cues. Members of the adamalysin protease subfamily, in particular the ADAM (a disintegrin and metalloprotease) and ADAMTS (the ADAM containing thrombospondin motif) families, are involved in these processes. This review presents an overview of how ADAM and ADAMTS proteins are involved in liver physiology and pathophysiology.
Zitieren
APA
Bolik, J., Tirnitz-Parker, J. E. E., & Schmidt-Arras, D. (2019). ADAM and ADAMTS Proteases in Hepatic Disorders. Journal of Renal and Hepatic Disorders. https://doi.org/10.15586/jrenhep.2019.47
Vancouver
Bolik J, Tirnitz-Parker JEE, Schmidt-Arras D. ADAM and ADAMTS Proteases in Hepatic Disorders. Journal of Renal and Hepatic Disorders. 2019. doi:10.15586/jrenhep.2019.47
BibTeX
@article{Bolik2019,
author = {Bolik, Julia and Tirnitz-Parker, Janina E. E. and Schmidt-Arras, Dirk},
title = {ADAM and ADAMTS Proteases in Hepatic Disorders},
journal = {Journal of Renal and Hepatic Disorders},
year = {2019},
doi = {10.15586/jrenhep.2019.47}
}
EUVIMED